Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.

Link:
Autor/in:
Erscheinungsjahr:
2010
Medientyp:
Text
Schlagworte:
  • Humans
  • Male
  • Adolescent
  • dosage
  • Neural Inhibition drug effects
  • Administration, Oral
  • Transcranial Magnetic Stimulation methods
  • Cerebral Cortex drug effects
  • Tetrahydrocannabinol administration
  • Tourette Syndrome blood
  • Humans
  • Male
  • Adolescent
  • dosage
  • Neural Inhibition drug effects
  • Administration, Oral
  • Transcranial Magnetic Stimulation methods
  • Cerebral Cortex drug effects
  • Tetrahydrocannabinol administration
  • Tourette Syndrome blood
Beschreibung:
  • To describe the clinical course of the Delta 9-tetrahydrocannabinol (Delta 9-THC) treatment of a boy with Gilles de la Tourette Syndrome (TS) and comorbid attention-deficit/hyperactivity disorder (ADHD) in relation to Delta 9-THC plasma levels and intracortical inhibition measured by transcranial magnetic stimulation.
  • To describe the clinical course of the Delta 9-tetrahydrocannabinol (Delta 9-THC) treatment of a boy with Gilles de la Tourette Syndrome (TS) and comorbid attention-deficit/hyperactivity disorder (ADHD) in relation to Delta 9-THC plasma levels and intracortical inhibition measured by transcranial magnetic stimulation.
Lizenz:
  • info:eu-repo/semantics/restrictedAccess
Quellsystem:
Forschungsinformationssystem des UKE
Interne Metadaten
Quelldatensatz
oai:pure.atira.dk:publications/4d087813-3274-423a-bc01-ef3059582ec7